Intravenous Iron in Patients Undergoing Maintenance Hemodialysis

2018471 citationsJournal Articlebronze Open Access

Authors

Iain C. Macdougall · Hull and East Yorkshire Hospitals NHS Trust

Claire White · Hull and East Yorkshire Hospitals NHS Trust

Stefan D. Anker · Hull and East Yorkshire Hospitals NHS Trust

Sunil Bhandari · Hull and East Yorkshire Hospitals NHS Trust

Kenneth Farrington · University of Hertfordshire

Philip A. Kalra · Hull and East Yorkshire Hospitals NHS Trust

John J.V. McMurray

Abstract

Among patients undergoing hemodialysis, a high-dose intravenous iron regimen administered proactively was superior to a low-dose regimen administered reactively and resulted in lower doses of erythropoiesis-stimulating agent being administered. (Funded by Kidney Research UK; PIVOTAL EudraCT number, 2013-002267-25 .).

Topics & Keywords

Iron Metabolism and Disorders Erythropoietin and Anemia Treatment Dialysis and Renal Disease Management

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 380, Issue 5, pp. 447-458

DOI: 10.1056/nejmoa1810742

Field-Weighted Citation Impact: 33.85